All-optical synaptic electrophysiology probes mechanism of ketamine-induced disinhibition.
Linlin Z FanRalda NehmeYoav AdamEun Sun JungHao WuKevin EgganDon B ArnoldAdam E CohenPublished in: Nature methods (2018)
Optical assays of synaptic strength could facilitate studies of neuronal transmission and its dysregulation in disease. Here we introduce a genetic toolbox for all-optical interrogation of synaptic electrophysiology (synOptopatch) via mutually exclusive expression of a channelrhodopsin actuator and an archaerhodopsin-derived voltage indicator. Optically induced activity in the channelrhodopsin-expressing neurons generated excitatory and inhibitory postsynaptic potentials that we optically resolved in reporter-expressing neurons. We further developed a yellow spine-targeted Ca2+ indicator to localize optogenetically triggered synaptic inputs. We demonstrated synOptopatch recordings in cultured rodent neurons and in acute rodent brain slice. In synOptopatch measurements of primary rodent cultures, acute ketamine administration suppressed disynaptic inhibitory feedbacks, mimicking the effect of this drug on network function in both rodents and humans. We localized this action of ketamine to excitatory synapses onto interneurons. These results establish an in vitro all-optical model of disynaptic disinhibition, a synaptic defect hypothesized in schizophrenia-associated psychosis.
Keyphrases
- drug induced
- prefrontal cortex
- high resolution
- high speed
- liver failure
- spinal cord
- high glucose
- pain management
- diabetic rats
- respiratory failure
- small molecule
- poor prognosis
- crispr cas
- bipolar disorder
- emergency department
- hepatitis b virus
- single molecule
- multiple sclerosis
- oxidative stress
- high throughput
- gene expression
- endothelial cells
- resting state
- brain injury
- dna methylation
- adverse drug
- case control
- subarachnoid hemorrhage
- nucleic acid